The DOI matches its Crossref record; 134 of the 134 references it cites were found in a registry or an index.
Pharmacology and functions of receptors for vasoactive intestinal peptide and pituitary adenylate cyclase‐activating polypeptide: IUPHAR Review 1
Open accessAbstract
Vasoactive intestinal peptide (VIP) and pituitary adenylate cyclase‐activating polypeptide (PACAP) are members of a superfamily of structurally related peptide hormones that includes glucagon, glucagon‐like peptides, secretin, gastric inhibitory peptide (GIP) and growth hormone‐releasing hormone (GHRH). VIP and PACAP exert their actions through three GPCRs – PAC 1, VPAC 1 and VPAC 2– belonging to class B (also referred to as class II, or secretin receptor‐like GPCRs). This family comprises receptors for all peptides structurally related to VIP and PACAP, and also receptors for parathyroid hormone, corticotropin‐releasing factor, calcitonin and related peptides. PAC 1 receptors are selective for PACAP, whereas VPAC 1 and VPAC 2 respond to both VIP and PACAP with high affinity. VIP and PACAP play diverse and important roles in the CNS, with functions in the control of circadian rhythms, learning and memory, anxiety and responses to stress and brain injury. Recent genetic studies also implicate the VPAC 2 receptor in susceptibility to schizophrenia and the PAC 1 receptor in post‐traumatic stress disorder. In the periphery, VIP and PACAP play important roles in the control of immunity and inflammation, the control of pancreatic insulin secretion, the release of catecholamines from the adrenal medulla and as co‐transmitters in autonomic and sensory neurons. This article, written by members of the International Union of Basic and Clinical Pharmacology Committee on Receptor Nomenclature and Drug Classification (NC‐IUPHAR) subcommittee on receptors for VIP and PACAP, confirms the existing nomenclature for these receptors and reviews our current understanding of their structure, pharmacology and functions and their likely physiological roles in health and disease. More detailed information has been incorporated into newly revised pages in the IUPHAR database (http://www.iuphar‐db.org/DATABASE/FamilyMenuForward?familyId=67). LINKED ARTICLES This article is part of a themed section on Secretin Family (Class B) G Protein‐Coupled Receptors. To view the other articles in this section visit http://dx.doi.org/10.1111/bph.2012.166.issue‐1
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Guide to receptors and channels (GRAC), 5th edition
Alexander, S., Mathie, A., & Peters, J. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01649_1.x · Cited by 1,947
Miyata, A., Arimura, A., Dahl, R. R., Minamino, N., Uehara, A., Jiang, L., Culler, M. D., & Coy, D. H. (1989) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(89)91757-9 · Cited by 1,830
Polypeptide with Broad Biological Activity: Isolation from Small Intestine
Said, S. I., & Mutt, V. (1970) · Science · doi:10.1126/science.169.3951.1217 · Cited by 1,596
Self-citationDifferential signal transduction by five splice variants of the PACAP receptor
Spongier, D., Waeber, C., Pantaloni, C., Holsboer, F., Bockaert, J., Seeburgt, P. H., & Journot, L. (1993) · Nature · doi:10.1038/365170a0 · Cited by 1,182
Pituitary Adenylate Cyclase-Activating Polypeptide and Its Receptors: 20 Years after the Discovery
Vaudry, D., Falluel-Morel, A., Bourgault, S., Basille, M., Burel, D., Wurtz, O., Fournier, A., Chow, B. K. C., Hashimoto, H., Galas, L., et al. (2009) · Pharmacological Reviews · doi:10.1124/pr.109.001370 · Cited by 1,058
Self-citationMiyata, A., Jiang, L., Dahl, R. D., Kitada, C., Kubo, K., Fujino, M., Minamino, N., & Arimura, A. (1990) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(90)92140-u · Cited by 917
Post-traumatic stress disorder is associated with PACAP and the PAC1 receptor
Ressler, K. J., Mercer, K. B., Bradley, B., Jovanovic, T., Mahan, A., Kerley, K., Norrholm, S. D., Kilaru, V., Smith, A. K., Myers, A. J., et al. (2011) · Nature · doi:10.1038/nature09856 · Cited by 800
Self-citationAton, S. J., Colwell, C. S., Harmar, A. J., Waschek, J., & Herzog, E. D. (2005) · Nature Neuroscience · doi:10.1038/nn1419 · Cited by 764
Self-citationIshihara, T., Shigemoto, R., Mori, K., Takahashi, K., & Nagata, S. (1992) · Neuron · doi:10.1016/0896-6273(92)90101-i · Cited by 745
Human preprovasoactive intestinal polypeptide contains a novel PHI-27-like peptide, PHM-27
Itoh, N., Obata, K.-I., Yanaihara, N., & Okamoto, H. (1983) · Nature · doi:10.1038/304547a0 · Cited by 683
The VPAC2 Receptor Is Essential for Circadian Function in the Mouse Suprachiasmatic Nuclei
Harmar, A. J., Marston, H. M., Shen, S., Spratt, C., West, K. M., Sheward, W. J., Morrison, C. F., Dorin, J. R., Piggins, H. D., Reubi, J.-C., et al. (2002) · Cell · doi:10.1016/s0092-8674(02)00736-5 · Cited by 549 · cited 4×
“…receptor indicate that this receptor is necessary for the generation of normal circadian rhythms of electrical activity, clock gene expression, physiology and behaviour (Harmar et al., 2002; Cutler et al., 2003; Hughes et al., 2004; Aton et al., 2005; Bechtold et al., 2008; Hannibal et al., 2011).”
BackgroundInfluentialSelf-citationSaid, S. I., & Mutt, V. (1972) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1972.tb01903.x · Cited by 526
Self-citationLutz, E. M., Sheward, W. J., West, K. M., Morrow, J. A., Fink, G., & Harmar, A. J. (1993) · FEBS Letters · doi:10.1016/0014-5793(93)81668-p · Cited by 497
Self-citationTatemoto, K., & Mutt, V (1981) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.78.11.6603 · Cited by 437
Levinson, D. F., Duan, J., Oh, S., Wang, K., Sanders, A. R., Shi, J., Zhang, N., Mowry, B. J., Olincy, A., Amin, F., et al. (2011) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2010.10060876 · Cited by 434
Usdin, T. B. (1994) · Endocrinology · doi:10.1210/en.135.6.2662 · Cited by 427
Disrupted circadian rhythms in VIP- and PHI-deficient mice
Colwell, C. S., Michel, S., Itri, J., Rodriguez, W., Tam, J., Lelievre, V., Hu, Z., Liu, X., & Waschek, J. A. (2003) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00200.2003 · Cited by 392
Self-citationArimura, A., & Shioda, S. (1995) · Frontiers in Neuroendocrinology · doi:10.1006/frne.1995.1003 · Cited by 384
VPAC and PAC receptors: From ligands to function
Dickson, L., & Finlayson, K. (2009) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2008.11.006 · Cited by 379
Pisegna, J. R., & Wank, S. A. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.13.6345 · Cited by 376
Self-citationDuplications of the neuropeptide receptor gene VIPR2 confer significant risk for schizophrenia
Vacic, V., McCarthy, S., Malhotra, D., Murray, F., Chou, H.-H., Peoples, A., Makarov, V., Yoon, S., Bhandari, A., Corominas, R., et al. (2011) · Nature · doi:10.1038/nature09884 · Cited by 337
SHIVERS, B. D., GÖRCS, T. J., GOTTSCHALL, P. E., & ARIMURA, A. (1991) · Endocrinology · doi:10.1210/endo-128-6-3055 · Cited by 321
Novel Receptor Partners and Function of Receptor Activity-modifying Proteins
Christopoulos, A., Christopoulos, G., Morfis, M., Udawela, M., Laburthe, M., Couvineau, A., Kuwasako, K., Tilakaratne, N., & Sexton, P. M. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.c200629200 · Cited by 309
Self-citationVillalba, M., Bockaert, J., & Journot, L. (1997) · The Journal of Neuroscience · doi:10.1523/jneurosci.17-01-00083.1997 · Cited by 306
Reubi, J. C., Läderach, U., Waser, B., Gebbers, J.-O., Robberecht, P., & Laissue, J. A. (2000) · PubMed · Cited by 287
Vasoactive intestinal peptide and electrical activity influence neuronal survival.
Brenneman, D. E., & Eiden, L. E. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.4.1159 · Cited by 284
Abad, C., Martinez, C., Juarranz, M. G., Arranz, A., Leceta, J., Delgado, M., & Gomariz, R. P. (2003) · Gastroenterology · doi:10.1053/gast.2003.50141 · Cited by 257
VIP: Molecular biology and neurobiological function
Gozes, I., & Brenneman, D. E. (1989) · Molecular Neurobiology · doi:10.1007/bf02740606 · Cited by 255
Self-citationYada, T., Sakurada, M., Ihida, K., Nakata, M., Murata, F., Arimura, A., & Kikuchi, M. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)42256-3 · Cited by 247
Hamelink, C., Tjurmina, O., Damadzic, R., Young, W. S., Weihe, E., Lee, H.-W., & Eiden, L. E. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.012608999 · Cited by 247
Inagaki, N., Yoshida, H., Mizuta, M., Mizuno, N., Fujii, Y., Gonoi, T., Miyazaki, J., & Seino, S. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.7.2679 · Cited by 246
Hashimoto, H., Nogi, H., Mori, K., Ohishi, H., Shigemoto, R., Yamamoto, K., Matsuda, T., Mizuno, N., Nagata, S., & Baba, A. (1996) · The Journal of Comparative Neurology · doi:10.1002/(sici)1096-9861(19960805)371:4<567::aid-cne6>3.0.co;2-2 · Cited by 228
Pantaloni, C., Brabet, P., Bilanges, B., Dumuis, A., Houssami, S., Spengler, D., Bockaert, J., & Journot, L. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.36.22146 · Cited by 223
Ghatei, M. A., Takahashi, K., Suzuki, Y., Gardiner, J., Jones, P. M., & Bloom, S. R. (1993) · Journal of Endocrinology · doi:10.1677/joe.0.1360159 · Cited by 209
Moro, O., & Lerner, E. A. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.2.966 · Cited by 202
Development of High Affinity Selective VIP1 Receptor Agonists
Gourlet, P., Vandermeers, A., Vertongen, P., Rathe, J., de Neef, P., Cnudde, J., Waelbroeck, M., & Robberecht, P. (1997) · Peptides · doi:10.1016/s0196-9781(97)00228-3 · Cited by 200
Ohtaki, H., Nakamachi, T., Dohi, K., Aizawa, Y., Takaki, A., Hodoyama, K., Yofu, S., Hashimoto, H., Shintani, N., Baba, A., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0600375103 · Cited by 197
Otto, C., Kovalchuk, Y., Wolfer, D. P., Gass, P., Martin, M., Zuschratter, W., Gröne, H. J., Kellendonk, C., Tronche, F., Maldonado, R., et al. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-15-05520.2001 · Cited by 193
Grace, C. R. R., Perrin, M. H., DiGruccio, M. R., Miller, C. L., Rivier, J. E., Vale, W. W., & Riek, R. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0404702101 · Cited by 193
Sorg, O., & Magistretti, P. (1992) · The Journal of Neuroscience · doi:10.1523/jneurosci.12-12-04923.1992 · Cited by 193
Jamen, F., Persson, K., Bertrand, G., Rodriguez-Henche, N., Puech, R., Bockaert, J., Ahrén, B., & Brabet, P. (2000) · Journal of Clinical Investigation · doi:10.1172/jci9387 · Cited by 190
Laburthe, M., Couvineau, A., & Tan, V. (2007) · Peptides · doi:10.1016/j.peptides.2007.04.026 · Cited by 189
Self-citationPACAP protects cerebellar granule neurons against oxidative stress‐induced apoptosis
Vaudry, D., Pamantung, T. F., Basille, M., Rousselle, C., Fournier, A., Vaudry, H., Beauvillain, J. C., & Gonzalez, B. J. (2002) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2002.01981.x · Cited by 188
Self-citationPisegna, J. R., & Wank, S. A. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.29.17267 · Cited by 185
Self-citationIn Vitro Properties of a High Affinity Selective Antagonist of the VIP1 Receptor
Gourlet, P., de Neef, P., Cnudde, J., Waelbroeck, M., & Robberecht, P. (1997) · Peptides · doi:10.1016/s0196-9781(97)00230-1 · Cited by 183
Vasoactive intestinal peptide prevents excitotoxic cell death in the murine developing brain.
Gressens, P., Marret, S., Hill, J. M., Brenneman, D. E., Gozes, I., Fridkin, M., & Evrard, P. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119545 · Cited by 173
Self-citationWaschek, J. A., Casillas, R. A., Nguyen, T. B., DiCicco-Bloom, E. M., Carpenter, E. M., & Rodriguez, W. I. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.16.9602 · Cited by 172
Self-citationCutler, D. J., Haraura, M., Reed, H. E., Shen, S., Sheward, W. J., Morrison, C. F., Marston, H. M., Harmar, A. J., & Piggins, H. D. (2003) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2003.02425.x · Cited by 172
Self-citationNicole, P., Lins, L., Rouyer-Fessard, C., Drouot, C., Fulcrand, P., Thomas, A., Couvineau, A., Martinez, J., Brasseur, R., & Laburthe, M. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m002325200 · Cited by 168
Self-citationWatanabe, T., Masuo, Y., Matsumoto, H., Suzuki, N., Ohtaki, T., Masuda, Y., Kitada, C., Tsuda, M., & Fujino, M. (1992) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(05)80159-7 · Cited by 166
Sreedharan, S. P., Huang, J. X., Cheung, M. C., & Goetzl, E. J. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.7.2939 · Cited by 163
Molecular pharmacology and structure of VPAC Receptors for VIP and PACAP
Laburthe, M., & Couvineau, A. (2002) · Regulatory Peptides · doi:10.1016/s0167-0115(02)00099-x · Cited by 162
Self-citationVaudry, D., Gonzalez, B. J., Basille, M., Fournier, A., & Vaudry, H. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.16.9415 · Cited by 160
Self-citationHannibal, J., Jamen, F., Nielsen, H. S., Journot, L., Brabet, P., & Fahrenkrug, J. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-13-04883.2001 · Cited by 158
Self-citationVaudry, D., Cottet‐Rousselle, C., Basille, M., Falluel‐Morel, A., Pamantung, T. F., Fontaine, M., Fournier, A., Vaudry, H., & Gonzalez, B. J. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.082112699 · Cited by 158
Self-citationShioda, S., Shuto, Y., Somogyvári-Vigh, A., Légrádi, G., Onda, H., Coy, D. H., Nakajo, S., & Arimura, A. (1997) · Neuroscience Research · doi:10.1016/s0168-0102(97)00065-5 · Cited by 155
High expression of peptide receptors as a novel target in gastrointestinal stromal tumours
Reubi, J. C., K�rner, M., Waser, B., Mazzucchelli, L., & Guillou, L. (2004) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-004-1476-2 · Cited by 154
Gourlet, P., Vertongen, P., Vandermeers, A., Vandermeers‐Piret, M., Rathé, J., NEEF, P. D., Waelbroeck, M., & Robberecht, P. (1997) · Peptides · doi:10.1016/s0196-9781(96)00322-1 · Cited by 151
Altered emotional behavior in PACAP-type-I-receptor-deficient mice
Otto, C., Martin, M., Wolfer, D. P., Lipp, H.-P., Maldonado, R. J., & Schütz, G. (2001) · Molecular Brain Research · doi:10.1016/s0169-328x(01)00153-x · Cited by 150
Transmitter Role of Vasoactive Intestinal Peptide
Fahrenkrug, J. (1993) · Pharmacology & Toxicology · doi:10.1111/j.1600-0773.1993.tb01344.x · Cited by 150
Self-citationHammack, S. E., Roman, C. W., Lezak, K. R., Kocho-Schellenberg, M., Grimmig, B. A., Falls, W. A., Braas, K. M., & May, V. (2010) · Journal of Molecular Neuroscience · doi:10.1007/s12031-010-9364-7 · Cited by 142
Self-citationSun, C. C., Song, D., Davis‐Taber, R., Barrett, L. W., Scott, V., Richardson, P. L., Pereda‐Lopez, A., Uchic, M. E., Solomon, L. R., Lake, M. R., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0611397104 · Cited by 138
Selective deficits in the circadian light response in mice lacking PACAP
Colwell, C. S., Michel, S. H., Itri, J. N., Rodriguez, W., Tam, J., Lelièvre, V., Hu, Z., & Waschek, J. A. (2004) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00268.2004 · Cited by 137
Self-citationVaudry, D., Gonzalez, B. J., Basille, M., Pamantung, T. F., Fontaine, M., Fournier, A., & Vaudry, H. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.24.13390 · Cited by 137
Self-citationSelective effects of vasoactive intestinal peptide on the mitogenic response of murine T cells.
Ottaway, C. A. (1987) · PubMed · Cited by 132
Mabuchi, T., Shintani, N., Matsumura, S., Okuda‐Ashitaka, E., Hashimoto, H., Muratani, T., Minami, T., Baba, A., & Ito, S. (2004) · Journal of Neuroscience · doi:10.1523/jneurosci.0983-04.2004 · Cited by 131
Goetzl, E. J., Voice, J. K., Shen, S., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.241503798 · Cited by 129
Tsutsumi, M., Claus, T. H., Liang, Y. T., Li, Y., Yang, L., Zhu, J., Cruz, F. D., Peng, X., Chen, H., Yung, S. L., et al. (2002) · Diabetes · doi:10.2337/diabetes.51.5.1453 · Cited by 127
PACAP Neurons in the Hypothalamic Ventromedial Nucleus Are Targets of Central Leptin Signaling
Hawke, Z., Ivanov, T. R., Bechtold, D. A., Dhillon, H., Lowell, B. B., & Luckman, S. M. (2009) · Journal of Neuroscience · doi:10.1523/jneurosci.1526-09.2009 · Cited by 124
Stroth, N., & Eiden, L. E. (2009) · Neuroscience · doi:10.1016/j.neuroscience.2009.11.023 · Cited by 124
Sheward, W. J., Lutz, E. M., & Harmar, A. J. (1995) · Neuroscience · doi:10.1016/0306-4522(95)00048-n · Cited by 123
Self-citationVPAC receptors: structure, molecular pharmacology and interaction with accessory proteins
Couvineau, A., & Laburthe, M. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01676.x · Cited by 122
Self-citationMounien, L., do-Rego, J.-C., Bizet, P., Boutelet, I., Gourcerol, G., Fournier, A., Brabet, P., Costentin, J., Vaudry, H., & Jégou, S. (2008) · Neuropsychopharmacology · doi:10.1038/npp.2008.73 · Cited by 119
Self-citationDelgado, M., Martínez, C., Johnson, M. C., et al. (1996) · Journal of Neuroimmunology · doi:10.1016/0165-5728(96)00063-x · Cited by 118
Martínez, C., Abad, C., Delgado, M., Arranz, A., Juarranz, M. G., Rodríguez‐Henche, N., Brabet, P., Leceta, J., & Gomariz, R. P. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.012367999 · Cited by 118
Hughes, A. T. L., Fahey, B., Cutler, D. J., Coogan, A. N., & Piggins, H. D. (2004) · Journal of Neuroscience · doi:10.1523/jneurosci.5345-03.2004 · Cited by 117
Reubi, J. C. (2000) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2000.tb06946.x · Cited by 115
Kienlen‐Campard, P., Crochemore, C., René, F., MONNIER, D., Koch, B., & Loeffler, J.-P. (1997) · DNA and Cell Biology · doi:10.1089/dna.1997.16.323 · Cited by 111
Class-B GPCR activation: is ligand helix-capping the key?
Neumann, J., Couvineau, A., Murail, S., Lacapère, J.-J., Jamin, N., & Laburthe, M. (2008) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2008.05.001 · Cited by 110
Self-citationVaudry, D., Gonzalez, B. J., Basille, M., Anouar, Y., Fournier, A., & Vaudry, H. (1998) · Neuroscience · doi:10.1016/s0306-4522(97)00545-9 · Cited by 108
Self-citationBasille, M., Vaudry, D., Coulouarn, Y., Jégou, S., Lihrmann, I., Fournier, A., Vaudry, H., & Gonzalez, B. J. (2000) · The Journal of Comparative Neurology · doi:10.1002/1096-9861(20001002)425:4<495::aid-cne3>3.0.co;2-a · Cited by 107
Self-citationLelièvre, V., Favrais, G., Abad, C., Adle‐Biassette, H., Lu, Y., Germano, P. M., Cheung-Lau, G. C., Pisegna, J., Gressèns, P., Lawson, G. W., et al. (2007) · Peptides · doi:10.1016/j.peptides.2007.05.006 · Cited by 106
Self-citationIUPHAR-DB: new receptors and tools for easy searching and visualization of pharmacological data
Sharman, J. L., Mpamhanga, C. P., Spedding, M., Germain, P., Staels, B., Dacquet, C., Laudet, V., Harmar, A. J., & NC-IUPHAR (2010) · Nucleic Acids Research · doi:10.1093/nar/gkq1062 · Cited by 106
Self-citationWei, Y., & Mojsov, S. (1996) · Journal of Neuroendocrinology · doi:10.1046/j.1365-2826.1996.05191.x · Cited by 104
Asnicar, M., Koster, A. M., Heiman, M. L., Tinsley, F. C., Smith, D. P., Galbreath, E. J., Fox, N. W., Ma, Y. L., Blum, W. F., & Hsiung, H. M. (2002) · Endocrinology · doi:10.1210/en.2002-220354 · Cited by 104
PACAP type I receptor activation regulates ECL cells and gastric acid secretion
Zeng, N., Athmann, C., Kang, T., Lyu, R., Walsh, J. H., Ohning, G., Sachs, G. M., & Pisegna, J. R. (1999) · Journal of Clinical Investigation · doi:10.1172/jci7537 · Cited by 104
Self-citationDistribution of the VPAC2 Receptor in Peripheral Tissues of the Mouse
Harmar, A. J., Sheward, W. J., Morrison, C. F., Waser, B., Gugger, M., & Reubi, J. C. (2003) · Endocrinology · doi:10.1210/en.2003-1058 · Cited by 103
Self-citationMalhotra, R. K., Wakade, T. D., & Wakade, A. R. (1988) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)69179-3 · Cited by 101
Vaudry, D., Falluel‐Morel, A., Basille, M., Pamantung, T. F., Fontaine, M., Fournier, A., Vaudry, H., & Gonzalez, B. J. (2003) · Journal of Neuroscience Research · doi:10.1002/jnr.10530 · Cited by 101
Self-citationTan, Y., Abad, C., Lopez, R., Dong, H., Liu, S., Lee, A. W., Gomariz, R. P., Leceta, J., & Waschek, J. A. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0812257106 · Cited by 99
Self-citationTherapeutic Effect of Vasoactive Intestinal Peptide on Experimental Autoimmune Encephalomyelitis
González‐Rey, E., Fernandez‐Martin, A., Chorny, A., Martin, J. J., Pozo, D., Ganea, D., & Delgado, M. (2006) · American Journal Of Pathology · doi:10.2353/ajpath.2006.051081 · Cited by 95
Vertongen, P., Schiffmann, S. N., Gourlet, P., & Robberecht, P. (1997) · Peptides · doi:10.1016/s0196-9781(97)00229-5 · Cited by 91
Przywara, D. A., Guo, X., Angelilli, M. L., Wakade, T. D., & Wakade, A. R. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.18.10545 · Cited by 91
Zusev, M., & Gozes, I. (2004) · Regulatory Peptides · doi:10.1016/j.regpep.2004.05.021 · Cited by 91
Self-citationVasoactive intestinal polypeptide biologic role in health and disease
Said, S. I. (1991) · Trends in Endocrinology and Metabolism · doi:10.1016/s1043-2760(05)80006-2 · Cited by 89
Self-citationMetabolic rhythm abnormalities in mice lacking VIP-VPAC2signaling
Bechtold, D. A., Brown, T. M., Luckman, S. M., & Piggins, H. D. (2007) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00667.2007 · Cited by 88
Voice, J. K., Grinninger, C., Kong, Y., Bangale, Y. A., Paul, S., & Goetzl, E. J. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.1.308 · Cited by 85
Besson, J., Sarrieau, A., Vial, M., Marie, J., Rosselin, G., & Rostène, W. H. (1986) · Brain Research · doi:10.1016/0006-8993(86)91493-9 · Cited by 85
Joumot, L., Waeber, C., Pantaloni, C., et al. (1995) · Biochemical Society Transactions · doi:10.1042/bst0230133 · Cited by 84
Martin, J., Dietl, M. M., Hof, P. R., Palacios, J. M., & Magistretti, P. J. (1987) · Neuroscience · doi:10.1016/0306-4522(87)90075-3 · Cited by 82
Changes in light-induced phase shift of circadian rhythm in mice lacking PACAP
Kawaguchi, C., Tanaka, K., Isojima, Y., Shintani, N., Hashimoto, H., Baba, A., & Nagai, K. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2003.09.004 · Cited by 81
Calcitonin and calcitonin receptor‐like receptors: common themes with family B GPCRs?
Barwell, J., Gingell, J. J., Watkins, H. A., Archbold, J. K., Poyner, D. R., & Hay, D. L. (2012) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01525.x · Cited by 80
PACAP centrally mediates emotional stress-induced corticosterone responses in mice
Tsukiyama, N., Saida, Y., Kakuda, M., Shintani, N., Hayata, A., Morita, Y., Tanida, M., Tajiri, M., Hazama, K., Ogata, K., et al. (2011) · Stress · doi:10.3109/10253890.2010.544345 · Cited by 79
Bourgault, S., Vaudry, D., Ségalas-Milazzo, I., Guilhaudis, L., Couvineau, A., Laburthe, M., Vaudry, H., & Fournier, A. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm900291j · Cited by 79
Self-citationMoreno, D., Gourlet, P., NEEF, P. D., Cnudde, J., Waelbroeck, M., & Robberecht, P. (2000) · Peptides · doi:10.1016/s0196-9781(00)00309-0 · Cited by 79
Møller, K., & Sundler, F. (1996) · Regulatory Peptides · doi:10.1016/0167-0115(96)00033-x · Cited by 77
Markedly reduced chronic nociceptive response in mice lacking the PAC1 receptor
Jongsma, H., Pettersson, L. M. E., Zhang, Y., Reimer, M. K., Kanje, M., Waldenström, A., Sundler, F., & Danielsen, N. (2001) · Neuroreport · doi:10.1097/00001756-200107200-00034 · Cited by 72
Matsuyama, S., Matsumoto, A., Hashimoto, H., Shintani, N., & Baba, A. (2003) · Neuroreport · doi:10.1097/00001756-200311140-00017 · Cited by 71
Neri, G., Andreis, P. G., Prayer‐Galetti, T., Rossi, G. P., Malendowicz, L., & Nussdorfer, G. G. (1996) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.81.1.8550747 · Cited by 70
Tan, Y., Couvineau, A., Murail, S., Ceraudo, E., Neumann, J., Lacapère, J.-J., & Laburthe, M. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m513305200 · Cited by 68
Self-citationJuarranz, Y. (2004) · British journal of rheumatology · doi:10.1093/rheumatology/keh061 · Cited by 68
Kumar, S., Pioszak, A. A., Zhang, C., Swaminathan, K., & Xu, H. E. (2011) · PLoS ONE · doi:10.1371/journal.pone.0019682 · Cited by 63
Zupan, V., Hill, J. M., Brenneman, D. E., Gozes, I., Fridkin, M., Robberecht, P., Evrard, P., & Gressèns, P. (1998) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1998.70052165.x · Cited by 61
Self-citationHannibal, J., Hsiung, H. M., & Fahrenkrug, J. (2010) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00599.2010 · Cited by 61
Self-citationNAP (Davunetide) Provides Functional and Structural Neuroprotection
Gozes, I. (2011) · Current Pharmaceutical Design · doi:10.2174/138161211795589373 · Cited by 58
Self-citationThe Family B1 GPCR: Structural Aspects and Interaction with Accessory Proteins
Couvineau, A., & Laburthe, M. (2011) · Current Drug Targets · doi:10.2174/138945012798868434 · Cited by 56
Self-citationMice lacking the PACAP type I receptor have impaired photic entrainment and negative masking
Hannibal, J., Brabet, P., & Fahrenkrug, J. (2008) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.90563.2008 · Cited by 55
Self-citationSzabadfi, K., Atlasz, T., Kiss, P., Dányádi, B., Tamás, A., Helyes, Z., Hashimoto, H., Shintani, N., Baba, A., Tóth, G. K., et al. (2011) · Neurotoxicity Research · doi:10.1007/s12640-011-9254-y · Cited by 55
Consequences of splice variation on Secretin family G protein‐coupled receptor function
Furness, S. G. B., Wootten, D. L., Christopoulos, A., & Sexton, P. M. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01571.x · Cited by 49
Abad, C., Tan, Y., Lopez, R., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1007622107 · Cited by 49
Neuroendocrine Significance of Vasoactive Intestinal Polypeptidea
Reichlin, S. (1988) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1988.tb26998.x · Cited by 49
Zaben, M., Sheward, W. J., Shtaya, A., Abbosh, C., Harmar, A. J., Pringle, A. K., & Gray, W. (2009) · Stem Cells · doi:10.1002/stem.184 · Cited by 45
Self-citationCharacterization of Intestinal and Pancreatic Dysfunction in VPAC1-Null Mutant Mouse
Fabricius, D., Karaçay, B., Shutt, D. C., Leverich, W., Schafer, B., Takle, E. J., Thedens, D. R., Khanna, G., Raikwar, S. P., Yang, B., et al. (2011) · Pancreas · doi:10.1097/mpa.0b013e318214c783 · Cited by 43
Identification and Characterization of a Small Molecule Antagonist of Human VPAC2 Receptor
Chu, A., Caldwell, J. S., & Chen, Y. A. (2009) · Molecular Pharmacology · doi:10.1124/mol.109.060137 · Cited by 39
Aubert, N., Vaudry, D., Falluel‐Morel, A., Desfeux, A., Fisch, C., Ancian, P., Jouffrey, S. D., Bigot, J.-F. L., Couvineau, A., Laburthe, M., et al. (2008) · Neurobiology of Disease · doi:10.1016/j.nbd.2008.06.014 · Cited by 35
Self-citationLee, H., Hahm, S. H., Hsu, C.-M., & Eiden, L. E. (1999) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1999.731769.x · Cited by 26
Tomimoto, S., Hashimoto, H., Shintani, N., Yamamoto, K., Kawabata, Y., Hamagami, K., Yamagata, K., Miyagawa, J.-I., & Baba, A. (2004) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.103.062919 · Cited by 26
Yon, L., Breault, L., Contesse, V., BELLANCOURT, G., Delarue, C., Fournier, A., Lehoux, J., Vaudry, H., & Gallo‐Payet, N. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.4.4690 · Cited by 23
Self-citationAdrenal responses to the peptide PACAP in conscious functionally hypophysectomized calves
Edwards, A. V., & Jones, C. T. (1994) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1994.266.6.e870 · Cited by 23
Dejda, A., Bourgault, S., Doan, N. D., Létourneau, M., Couvineau, A., Vaudry, H., Vaudry, D., & Fournier, A. (2010) · Biochimie · doi:10.1016/j.biochi.2010.12.010 · Cited by 21
Self-citationKawai, K., Yokota, C., Ohashi, S., Isobe, K., Suzuki, S., Nakai, T., & Yamashita, K. (1994) · Metabolism · doi:10.1016/0026-0495(94)90124-4 · Cited by 19
Yon, L. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.83.4.1299 · Cited by 18
Shioda, S., Shimoda, Y., Hori, T., Mizushima, H., Ajiri, T., Funahashi, H., Ohtaki, K., & Ryushi, T. (2000) · Neuroscience Letters · doi:10.1016/s0304-3940(00)01595-0 · Cited by 14
Piggins, H. D. (2011) · Nature · doi:10.1038/471455a · Cited by 8
Cited by
Pharmacology, Physiology, and Mechanisms of Action of Dipeptidyl Peptidase-4 Inhibitors
Mulvihill, E. E., & Drucker, D. J. (2014) · Endocrine Reviews · doi:10.1210/er.2014-1035 · Cited by 609
The Concise Guide to PHARMACOLOGY 2013/14: G Protein‐Coupled Receptors
Alexander, S. P. H., Benson, H. E., Faccenda, E., Pawson, A. J., Sharman, J. L., Spedding, M., Peters, J. A., Harmar, A. J., & Collaborators, C. (2013) · British Journal of Pharmacology · doi:10.1111/bph.12445 · Cited by 556
Self-citationThe Concise Guide to PHARMACOLOGY 2023/24: G protein-coupled receptors
Alexander, S. P. H., Christopoulos, A., Davenport, A. P., Kelly, E., Mathie, A. A., Peters, J. A., Veale, E. L., Armstrong, J. F., Faccenda, E., Harding, S. D., et al. (2023) · British Journal of Pharmacology · doi:10.1111/bph.16177 · Cited by 392
Self-citationErectile dysfunction and diabetes: A melting pot of circumstances and treatments
Defeudis, G., Mazzilli, R., Tenuta, M., Rossini, G., Zamponi, V., Olana, S., Faggiano, A., Pozzilli, P., Isidori, A. M., & Gianfrilli, D. (2022) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.3494 · Cited by 285
Amin, F. M., Hougaard, A., Schytz, H. W., Asghar, M. S., Lundholm, E., Parvaiz, A. I., de Koning, P. J. H., Andersen, M. R., Larsson, H. B. W., Fahrenkrug, J., et al. (2014) · Brain · doi:10.1093/brain/awt369 · Cited by 262
Self-citation
Metadata
- Authors
- Harmar, A. J., Fahrenkrug, J., Gozes, I., Laburthe, M., May, V., Pisegna, J. R., Vaudry, D., Vaudry, H., Waschek, J. A., & Said, S. I.
- Venue
- British Journal of Pharmacology
- Publisher
- Wiley
- Published
- 2012-04-10
- Volume
- 166
- Issue
- 1
- Pages
- 4-17
- ISSN
- 0007-1188 (ISSN-L)
- 1476-5381
- OpenAlex
- W1722148928
- Cited by
- 471
- References
- 134
- FWCI
- 12.85
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.